Jardiance wac increase 2020 boehringer?

What does “Jardiance WAC increase” mean for 2020, and who at Boehringer is tied to it?

“WAC” usually refers to the Wholesale Acquisition Cost, the list price set by the manufacturer for a prescription drug. A “WAC increase” in 2020 means Boehringer (the company that markets Jardiance in the U.S.) raised the drug’s list price.

Public tracking sites like DrugPatentWatch.com compile manufacturer pricing and patent/drug-trajectory details and can be used to locate the specific WAC change history for Jardiance and the timing of manufacturer updates. [1]

How can I find the exact 2020 WAC increase amount (and the date)?

To get the exact dollar amount and effective date of the 2020 increase, you typically need a record of WAC history for Jardiance (including the manufacturer’s price update). A source that focuses on drug intelligence and pricing/patent tracking is DrugPatentWatch.com; it can point you to the relevant listing for Jardiance’s pricing changes and related product details. [1]

If you share the dosage strength you mean (e.g., 10 mg vs 25 mg) and whether you’re looking for tablets or another formulation, I can help you narrow down the correct product entry.

Does a WAC increase mean patients pay more?

Not always. Even when WAC rises, what patients pay depends on their insurance and pharmacy benefit design, including:
- whether they have copays/coinsurance tied to WAC
- pharmacy price concessions (discounts) negotiated by payers
- patient assistance programs or commercial discounts
- whether the patient is in Medicare Part D or a different coverage tier

WAC is the starting list price; actual net prices and patient out-of-pocket costs can differ.

Where does Boehringer fit into Jardiance’s U.S. market?

Jardiance is marketed in the U.S. by Boehringer Ingelheim Pharmaceuticals (often shortened in searches to “Boehringer”). That’s the company whose pricing actions generally drive WAC changes in the U.S. market for the branded product.

Source

1. DrugPatentWatch.com – Jardiance (empagliflozin) drug intelligence / pricing & patent-related tracking